Shell Companies · Financial Services
CFO, CEO
2026-09-02–present
Equibles does not estimate personal net worth.
Jing-Zhou Chen is recorded as CFO and CEO at Acro Biomedical Co., Ltd. (ACBM) since September 2, 2026. Acro Biomedical Co., Ltd. reported in an 8-K filed September 2, 2026 that Jing-Zhou Chen was appointed chief executive officer and chief financial officer, effective September 2, 2026. Acro Biomedical Co., Ltd. reported in an 8-K filed September 2, 2026 that Jing-Zhou Chen was appointed chief executive officer and chief financial officer, effective September 2, 2026. Acro Biomedical Co., Ltd. is classified in the Shell Companies industry within the Financial Services sector. Other leadership on record at Acro Biomedical Co., Ltd. includes Yu-Ting, Su (CEO, Chairman and Board Member), Shao-Hsiang Shih (Chairman) and Pao-Chi Chu (Board Member).
“On September 2, 2026, the Company's board of directors appointed Jing-Zhou Chen as chief executive officer and chief financial officer, effective on September 2, 2026.”
“On September 2, 2026, the Company's board of directors appointed Jing-Zhou Chen as chief executive officer and chief financial officer, effective on September 2, 2026.”
2026-09-02–present
2026-09-02–present
Shell Companies · Financial Services
CFO, CEO
2026-09-02–present